tiprankstipranks
Trending News
More News >
Epigenomics AG (GB:0QXH)
:0QXH
UK Market

Epigenomics (0QXH) Income Statement

Compare
0 Followers

Epigenomics Income Statement

Last quarter (Q3 2022), Epigenomics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Epigenomics's net income was $-1.56M. See Epigenomics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 6.07M$ 697.00K$ 871.00K$ 1.07M$ 1.64M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 249.00K$ 281.00K$ 246.00K$ 87.00K$ 81.00K
EBITDA
$ -1.94M$ -11.07M$ -13.99M$ -12.57M$ -9.93M
Operating Income
$ -4.16M$ -10.11M$ -15.10M$ -13.29M$ -9.86M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.43M$ -11.69M$ -17.02M$ -12.69M$ -10.23M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Epigenomics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis